NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation

SIMPLE SUMMARY: Tumor dormancy is a state in which some cancer cells are dormant by less cell proliferation, and are resistant to treatments, thus leading to late recurrence. As nuclear receptor subfamily 2 group F member 1 (NR2F1) is a biomarker of dormancy shown in experimental settings, we studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Rongrong, Roy, Arya Mariam, Tokumaru, Yoshihisa, Gandhi, Shipra, Asaoka, Mariko, Oshi, Masanori, Yan, Li, Ishikawa, Takashi, Takabe, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220877/
https://www.ncbi.nlm.nih.gov/pubmed/35740627
http://dx.doi.org/10.3390/cancers14122962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220877/
https://www.ncbi.nlm.nih.gov/pubmed/35740627
http://dx.doi.org/10.3390/cancers14122962

Ejemplares similares